Consolidated Condensed Statements of Operations - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Jul. 26, 2026	Jul. 27, 2025	Jul. 26, 2026	Jul. 27, 2025
Income Statement [Abstract]
Revenue	$ 9,115	$ 7,302	$ 24,037	$ 21,568
Cost of products sold	4,529	3,740	12,069	11,025
Gross profit	4,586	3,562	11,968	10,543
Operating expenses:
Research, development and engineering	1,100	901	3,055	2,653
Marketing and selling	249	224	704	646
General and administrative	162	204	515	667
Legal settlement	0	0	253	0
Restructuring charges	0	0	12	0
Total operating expenses	1,511	1,329	4,539	3,966
Income from operations	3,075	2,233	7,429	6,577
Interest expense	68	66	206	198
Interest and other income (expense), net	(100)	396	1,237	625
Income before income taxes	2,907	2,563	8,460	7,004
Provision for income taxes	369	784	1,090	1,903
Net income	$ 2,538	$ 1,779	$ 7,370	$ 5,101
Earnings per share:
Basic (in dollars per share)	$ 3.20	$ 2.23	$ 9.29	$ 6.32
Diluted (in dollars per share)	$ 3.17	$ 2.22	$ 9.22	$ 6.29
Weighted average number of shares:
Basic (in shares)	794	798	794	807
Diluted (in shares)	800	802	799	811

Consolidated Condensed Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Jul. 26, 2026	Jul. 27, 2025
Cash flows from operating activities:
Net income	$ 7,370	$ 5,101
Adjustments required to reconcile net income to cash provided by operating activities:
Depreciation and amortization	413	321
Restructuring charges	12	0
(Gain) / loss and impairment on investments	(909)	(270)
Share-based compensation	545	512
Deferred income taxes	25	952
Other	(11)	(28)
Changes in operating assets and liabilities:
Accounts receivable	(2,508)	(538)
Inventories	(609)	(386)
Other current and non-current assets	(333)	(36)
Accounts payable and accrued expenses	412	135
Contract liabilities	698	(379)
Income taxes payable	462	(297)
Other liabilities	1	43
Cash provided by operating activities	5,568	5,130
Cash flows from investing activities:
Capital expenditures	(1,988)	(1,475)
Cash paid for acquisitions, net of cash acquired	(262)	(29)
Proceeds from asset sale	6	33
Proceeds from sales and maturities of investments	4,585	3,937
Purchases of investments	(5,493)	(5,109)
Cash used in investing activities	(3,152)	(2,643)
Cash flows from financing activities:
Proceeds from issuance of commercial paper	399	400
Repayments of commercial paper	(400)	(400)
Proceeds from common stock issuances	131	129
Common stock repurchases	(1,177)	(4,044)
Tax withholding payments for vested equity awards	(437)	(210)
Payments of dividends to stockholders	(1,150)	(1,019)
Payments of debt issuance costs	0	(2)
Cash used in financing activities	(2,634)	(5,146)
Increase (decrease) in cash, cash equivalents and restricted cash equivalents	(218)	(2,659)
Cash, cash equivalents and restricted cash equivalents — beginning of period	7,312	8,113
Cash, cash equivalents and restricted cash equivalents — end of period	7,094	5,454
Reconciliation of cash, cash equivalents and restricted cash equivalents
Cash and cash equivalents	7,037	5,384
Restricted cash equivalents included in deferred income taxes and other assets	57	70
Total cash, cash equivalents and restricted cash equivalents	7,094	5,454
Supplemental cash flow information:
Cash payments for income taxes	819	1,269
Cash refunds from income taxes	22	79
Cash payments for interest	$ 192	$ 171

Consolidated Condensed Balance Sheets - USD ($) $ in Millions	Jul. 26, 2026	Oct. 26, 2025
Current assets:
Cash and cash equivalents	$ 7,037	$ 7,241
Short-term investments	2,196	1,332
Accounts receivable, net	7,691	5,185
Inventories	6,564	5,915
Other current assets	1,607	1,208
Total current assets	25,095	20,881
Long-term investments	5,268	4,327
Property, plant and equipment, net	5,606	4,610
Goodwill	3,873	3,707
Purchased technology and other intangible assets, net	315	226
Deferred income taxes and other assets	3,365	2,548
Total assets	43,522	36,299
Current liabilities:
Short-term debt	1,299	100
Accounts payable and accrued expenses	5,787	5,333
Contract liabilities	3,271	2,566
Total current liabilities	10,357	7,999
Long-term debt	5,245	6,455
Income taxes payable	880	356
Other liabilities	1,414	1,074
Total liabilities	17,896	15,884
Stockholders’ equity:
Common stock	8	8
Additional paid-in capital	10,572	10,333
Retained earnings	61,391	55,227
Treasury stock	(46,180)	(45,043)
Accumulated other comprehensive loss	(165)	(110)
Total stockholders’ equity	25,626	20,415
Total liabilities and stockholders’ equity	$ 43,522	$ 36,299